We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Diagnostic Accuracy of New Dengue Capture Assay Evaluated

By LabMedica International staff writers
Posted on 08 Apr 2015
Print article
Image: The Dengue Duo Cassette rapid immunochromatographic test used to detect IgM and high-titer IgG antibodies to dengue virus in human serum, plasma and whole blood (Photo courtesy of Panbio).
Image: The Dengue Duo Cassette rapid immunochromatographic test used to detect IgM and high-titer IgG antibodies to dengue virus in human serum, plasma and whole blood (Photo courtesy of Panbio).
Image: An enzyme-linked immunosorbent (ELISA) kit used to detect elevated antibodies to dengue virus (serotypes 1-4) in patients with secondary infection (Photo courtesy of Panbio).
Image: An enzyme-linked immunosorbent (ELISA) kit used to detect elevated antibodies to dengue virus (serotypes 1-4) in patients with secondary infection (Photo courtesy of Panbio).
Dengue disease has become a major global public health concern, but an ideal diagnostic test that permits early and rapid diagnosis is not yet available, so improving diagnostic performance in this area is a major challenge.

The kinetics of dengue infection in serum is accorded by virus isolation and nucleic acid or antigen detection which are the most specific diagnostic methods during the early acute stage of disease, while serology is often used for diagnosis later in the course of infection.

Scientists at the Pasteur Institute (Cayenne, French Guiana) selected 184 sera for evaluation included two groups: a group of 134 sera from confirmed dengue-infected patients and a second group of 50 sera from non-dengue infected patients. Sera were classified according to the onset of fever. Day zero was defined as sera collected within 24 hours after the onset of fever. Detection of specific dengue immunoglobulin M (IgM) was carried out using an in-house IgM capture enzyme-linked immunosorbent assay (MAC-ELISA).

The dengue virus (DENV) nonstructural protein (NS1) antigen was detected using the commercial Platelia Dengue NS1 AG antigen-capture enzyme-linked immunosorbent assay (ELISA) (Bio-Rad Laboratories; Marnes La Coquette, France). The Bio-Rad Platelia Dengue IgA Capture is a microplate immunoassay using immuno-capture format for detection of specific IgA against DENV in human serum or plasma. Detections of specific dengue IgM and IgG were carried out using the Panbio Dengue IgM Capture ELISA and the Panbio Dengue IgG Capture ELISA kits (Panbio; Brisbane, Australia).

Out of the 134 dengue group sera, the IgA index assay detected 124 positive, indicating a sensitivity of 93%. Six sera out of the 50 non-dengue group ones were also found IgA positive, demonstrating a specificity of 88%. Seropositivities for IgA broadly increased from 50% for sera collected three to four days after the onset of fever to 100% for those collected seven days after. The IgA test had very good sensitivity for detecting infections caused by three dengue serotypes (DENV-2, DENV-3, DENV-4, with sensitivities of 100%, 97% and 92% respectively), while its ability to detect infection caused by DENV-1 was significantly less efficient (85%). The IgA assay had a good concordance with the Panbio IgM capture ELISA.

The authors concluded that the Platelia Dengue IgA Capture assay is an acceptable test, with overall sensitivity and specificity of about 90%. The IgA test assay is a more accurate dating of infection when used to measure a good quality serological marker detectable in acute-phase serum and persisting for a shorter period of time than dengue specific IgM allows. The study was published on March 24, 2015, in the journal Public Library of Science Neglected Tropical Diseases.

Related Links:

Pasteur Institute
Bio-Rad Laboratories
Panbio 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: A blood test could predict lung cancer risk more accurately and reduce the number of required scans (Photo courtesy of 123RF)

Blood Test Accurately Predicts Lung Cancer Risk and Reduces Need for Scans

Lung cancer is extremely hard to detect early due to the limitations of current screening technologies, which are costly, sometimes inaccurate, and less commonly endorsed by healthcare professionals compared... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The QIAseq xHYB Mycobacterium tuberculosis Panel uses next-generation sequencing (Photo courtesy of 123RF)

New Mycobacterium Tuberculosis Panel to Support Real-Time Surveillance and Combat Antimicrobial Resistance

Tuberculosis (TB), the leading cause of death from an infectious disease globally, is a contagious bacterial infection that primarily spreads through the coughing of patients with active pulmonary TB.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.